Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
Authors:
- Linda A. GalloLGLinda A. Gallo
- Micheal S. WardMWMicheal S. Ward
- Amelia K. FotheringhamAFAmelia K. Fotheringham
- Aowen ZhuangAZAowen Zhuang
- Danielle J. BorgDBDanielle J. Borg
- Nicole B. FlemmingNFNicole B. Flemming
- Ben M. HarvieBHBen M. Harvie
- Toni L. KinneallyTKToni L. Kinneally
- Shang-Ming YehSYShang-Ming Yeh
- Domenica A. McCarthyDMDomenica A. McCarthy
- Hermann KoepsellHKHermann Koepsell
- Volker VallonVVVolker Vallon
Open Access
- 7 July 2016
- journal article
- correction
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 28124